Spatial association of apoptosis-related gene expression and cellular death in clinical neuroblastoma

British Journal of Cancer

Volumn 75, Issue 8, 1997, Pages 1185-1194

  Hoehner, J C ^a,c   Gestblom, C ^b   Olsen, L ^a   Pahlman S ^b  

^a UPPSALA UNIVERSITY HOSPITAL   (Sweden)

^b LUND UNIVERSITY   (Sweden)

^c HOSPITAL FOR SICK CHILDREN   (Canada)

Author keywords

Angiogenesis; Architecture; Bcl 2; Neuroblastoma: apoptosis; p53

Indexed keywords

CYCLINE; DNA FRAGMENT; PROTEIN BAX; PROTEIN BCL 2; PROTEIN P53; RETINOBLASTOMA PROTEIN;

APOPTOSIS; ARTICLE; CANCER SURVIVAL; CELL DIFFERENTIATION; CELL PROLIFERATION; CHILD; CLINICAL ARTICLE; DNA DEGRADATION; FEMALE; GENE EXPRESSION; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MALE; NEUROBLASTOMA; PRESCHOOL CHILD; PRIORITY JOURNAL; PROTEIN EXPRESSION; SCHOOL CHILD;

EID: 0030974517     PISSN: 00070920     EISSN: None     Source Type: Journal    
DOI: 10.1038/bjc.1997.203     Document Type: Article

References (81)

1. Altsopp TE, Wyatt S, Paterson HF and Davies AM (1993) The proto-oncogene bcl-2 can selectively rescue neurotrophic factor-dependent neurons from apoptosis. Cell 73: 295-307
2. Arends MJ, McGregor AH and Wyllie AH (1994) Apoptosis is inversely related to necrosis and determines net growth in tumors bearing constitutively expressed myc, ras, and HPV oncogenes. Am J Pathol 144: 1045-1057
3. Beckwith JB and Martin RF (1968) Observations on the histologic theory of neuroblastomas. J Pediatr Surg 3: 106-110
4. Beckwith JB and Perrin E (1962) In situ neuroblastomas: a contribution to the natural history of neural crest tumours. Am J Pathol 43: 1089-1104
5. Brodeur GM (1995) Molecular basis for heterogencity in human neuroblastoma. Eur J Cancer 31A: 505-510
6. Brodeur G, Pritchard J, Berthold E Carlsen N, Castel V, Castleberry R, Debernardi B, Evans A, Favrot M, Hedborg F, Kaneko M, Kemshead J, Lamperl F, Lee R, Look T, Pearson A, Philip T, Roald B, Sawada T, Seeger R, Tsuchida Y and Voute P (1993) Revisions of the international criteria for neuroblastoma diagnosis, staging, and response to treatment. J Clin Oncol 11; 1466-1477
7. Buchkovich K, Duffy LA and Harlow E (1989) The retinoblastoma protein is phosphorylated during specific phases of the cell cycle. Cell 58: 1097-1105
8. Castle VP, Heidelberger KP, Bromberg J, Ou X, Dole M and Nunez G (1993) Expression of the apoptosis-suppressing protein bcl-2 in neuroblastoma is associated with unfavourable histology and N-myc amplification. Am J Pathol 143: 1543-1550
9. Chen PL, Scully P, Shew J-Y, Wang JY and Lee WH (1989) Phosphorylation of the retinoblastoma gene product is modulated during the cell cycle and cellular differentiation. Cell 58: 1193-1198
10. Cho Y, Gorina S, Jeffrey PD and Pavletich NP (1994) Crystal structure of a p53 tumor suppressor-DNA complex: understanding tumorigenic mutations. Science 265: 346-355
11. Cordon-Cardo C (1995) Mutation of cell cycle regulators. Biological and clinical implications for human neoplasia. Am J Pathol 147; 545-560
12. Cordon-Cardo C and Richon VM (1994) Expression of the retinoblastoma protein is regulated in normal human tissues. Am J Pathol 144: 500-510
13. Cory S, Harris AW and Strasser A (1994) Insights from transgenic mice regarding the role of bcl-2 in normal and neoplastic lymphoid cells. Phil Trans R Soc Lond B 345: 289-295
14. D'Angio G, Evans AE and Koop CE (1971) Special pattern of wide-spread neuroblastoma with a favourable prognosis. Lancet 1: 1046-1049
15. Davidoff AM, Pence JC, Shorter NA, Iglehart JD and Marks JR (1992) Expression of p53 in human neuroblastoma- and neuroepithelioma-derived cell lines. Oncogene 7: 127-133
16. Dowell SP and Hall PA (1994) The clinical relevance of the p53 tumor suppressor gene. Cytopathology 5: 133-145
17. EI-Deiry WS, Tokino T, Velculescu VE, Levy DB, Parsons R, Trent JM, Lin D, Mercer WE, Kinzler KW and Vogelstein B (1993) WAFI a potential mediator of p53 tumor suppression. Cell 75: 817-825
18. Evans AE, D'Angio GJ and Randolph JA (1971) A proposed staging for children with neuroblastoma. Cancer 27: 374-378
19. Evans AE, Gerson J and Schnaufer L (1976a) Spontaneous regression of neuroblastoma. Natl Cancer Inst Monogr 44: 49-55
20. Evans AE, Albo V and D'Angio GJ (1976b) Factors influencing survival of children with nonmetastatic neuroblastoma. Cancer 38: 661-666
21. Everson T and Cole W (1966) Spontaneous Regression of Cancer. WB Saunders Co: Philadelphia
22. Folkman J (1990) What is the evidence that tumors are angiogenesis dependent? J Natl Cancer Inst 82: 4-6
23. Folkman J, Cole P and Zimmerman S (1966) Tumor behavior in isolated perfused organs: in vitro growth and metastasis of biopsy material in rabbit thyroid and canine intestinal segment. Ann Surg 164: 491-502
24. Franko AJ and Sutherland RM (1979) Oxygen diffusion distance and development of necrosis in multicell spheroids. Radiat Res 79: 439-453
25. Garcia I, Martinou I, Tsujimoto Y and Martinou J (1992) Prevention of programmed cell death of sympathetic neurons by the bcl-2 proto-oncogene. Science 258: 302-304
26. Gavrieli Y, Sherman Y and Ben-Sasson SA (1992) Identification of programmed cell death in situ via specific labeling of DNA fragmentation. J Cell Biol 119: 493-501
27. Gestblom C, Hoehner JC and Påhlman S (1995) Proliferation and apoptosis in neuroblastoma: subdividing the mitosis-karyorrhexis index. Eur J Cancer 31A: 458-463
28. Gimbrone MAJ, Cotran RS and Leapman SB (1974) Tumor growth and neovascularization: an experimental model using the rabbit cornea. J Natl Cancer Inst 52: 413-427
29. Greenblatt MS, Bennett WP, Hollstein M and Harris CC (1994) Mutations in the p53 tumor suppressor gene: clues to cancer etiology and molecular pathogenesis. Cancer Res 54: 4855-4878
30. Greenlund LJS, Korsmeyer SJ and Johnson EMJ (1995) Role of Bcl-2 in the survival and function of developing and mature sympathetic neurons. Neuron 15: 649-661
31. Haas-Kogan DA, Kogan SC, Levi D, Dazin P, T'Ang A, Fung Y-KT and Israel MA (1995) Inhibition of apoptosis by the retinoblastoma gene product. EMBO J 14: 461-472
32. Hall PA and Lane DP (1994) p53 in tumour pathology: can we trust immunohistochemistry?-revisited. J Pathol 172: 1-4
33. Hall PA, Levison DA, Woods AL, Yu CC, Kellock DB, Watkins JA, Barnes DM, Gillen CE, Camplejohn R and Dover R (1990) Proliferating cell nuclear antigen (PCNA) immunolocalization in paraffin sections: an index of cell proliferation with evidence of deregulated expression in some neoplasms. J Pathol 162: 284-294
34. Hall PA, McKee PH, Menage HD, Dover R and Lane DP (1993) High levels of p53 protein in UV irradiated normal human skin. Oncogene 8: 203-207
35. Harper JW, Adami GR, Wei N, Keyomarsi K and Elledge SJ (1993) The p21 cdk-interacting protein Cip1 is a potent inhibitor of G1 cyclin-dependent kinases. Cell 75: 805-816
36. Hedborg F, Ohlsson R, Sandstedt B, Grimelius L, Hoehner JC and Påhlman S (1995a) IGF2 expression is a marker for paraganglionic/SIF cell differentiation in neuroblastoma. Am J Pathol 146: 833-847
37. Hedborg F, Bjelfman C, Sparen P, Sandstedt B and P̊hlman S (1995b) Biochemical evidence for a mature phenotype in morphologically poorly differentiated neuroblastomas with favourable outcome. Eur J Cancer 31A: 435-443
38. Hockenbery DM, Zutter M, Hickey W, Nahm M and Korsmeyer SJ (1991) Bel2 protein is topographically restricted in tissues characterized by apoptotic cell death. Proc Natl Acad Sci USA 88: 6961-6965
39. Hoehner JC, Hedborg F, Sandstedt B, Olsen L and Påhlman S (1995a) Cellular death in neuroblastoma: in situ correlation of apoptosis and Bcl-2 expression. Int J Cancer 62: 19-24
40. Hoehner JC, Olsen L, Sandstedt B, Kaplan DR and Påhlman S (1995b) Association of neurotrophin receptor expression and differentiation in human neuroblastoma. Am J Pathol 147: 102-113
41. Hosoi G, Hara J, Okamura T, Osugi Y, Ishihara S, Fukuzawa M, Okada A, Okada S and Tawa A (1994) Low frequency of the p53 gene mutations in neuroblastoma. Cancer 73: 3087-3093
42. Ikegaki N, Temeles G and Kennett RH (1991) Modulation of protein expression associated with chemically induced differentiation of neuroblastoma cells. Prog Clin Biol Res USA 366: 157-163
43. Ikegaki N, Kastumata M and Tsujimoto Y (1994) The expression and modulation of proteins associated with physiological cell death in neuroblastoma cells. Prog Clin Biol Res USA 385: 117-122
44. Ikegaki N, Katsumata M, Tsujimoto Y, Nakagawara A and Brodeur GM (1995) Relationship between bcl-2 and myc gene expression in human neuroblastoma. Cancer Lett 91: 161-168
45. Imamura J, Bartram CR, Berthold F, Harms D, Nakamura H and Koeffler HP (1993) Mutation of the p53 gene in neuroblastoma and its relationship with N-myc amplification. Cancer Res 53: 4053-4058
46. Jaequemier J, Moles JP, Penault-Llorca F, Adelaide J, Torrente M, Viens P, Birnbaum D and Theillet C (1994) p53 immunohistochemical analysis in breast cancer with four monoclonal antibodies: comparison of staining and PCR-SSCP results. Br J Cancer 69: 846-852
47. Kastan MB, Onkyekwere O, Sidransky D. Vogelstein B and Craig RW (1991) Participation of p53 protein in the cellular response to DNA damage. Cancer Res 51: 6304-6311
48. Kerr JFR, Wyllie AH and Currie AR (1972) Apoptosis: a basic biological phenomenon with wide-ranging implications in tissue kinetics. Br J Cancer 26: 239-257
49. Krajewski S, Chatten J, Hanada M and Reed JC (1995) Immunohistochemical analysis of the bcl-2 oncoprotein in human neuroblastomas. Comparisons with tumor cell differentiation and N-Myc protein. Lab Invest 71: 42-52
50. Krajewski S, Krajewska M, Shabaik A, Miyashita T. Wang HG and Reed JC (1994) Immunohistochemical determination of in vivo distribution of Bax, a dominant inhibitor of Bcl-2. Am J Pathol 145: 1323-1336
51. Kurki P, Ogata K, Tan EM and Keck WM (1988) Monoclonal antibodies to proliferating cell nuclear antigen (PCNA)/cyclin as probes for proliferating cells by immunofluorescence microscopy and flow cytometry. J Immunol Methods 109: 49-59
52. Lane DP (1993) A death in the life of p53. Nature 362: 786-787
53. Lane DP (1994) The regulation of p53 function: Steiner award lecture. Int J Cancer 57: 623-627
54. Lebrun DP, Warnke RA and Cleary ML (1993) Expression of bcl-2 in fetal tissues suggests a role in morphogenesis. Am J Pathol 142: 743-753
55. Lu O, Poulsom R, Wong L and Hanby AM (1993) bcl-2 expression in adult and embryonic non-haematopoietic tissues. J Pathol 169: 431-437
56. Lu X and Lane DP (1993) Differential induction of transcriptionally active p53 following UV or ionizing radiation: defects in chromosome instability syndromes? Cell 75: 765-778
57. Maltzman W and Czyzyk L (1984) UV irradiation stimulates levels of p53 cellular tumour antigen in nontransformed mouse cells. Mol Cell Biol 4: 1689-1694
58. Miyashita T, Krajewski S, Krajewska M, Wang HG, Lin HK, Liebermann DA. Hoffman B and Reed JC (1994) Tumor suppressor p53 is a regulator of bcl-2 and bax gene expression in vitro and in vivo. Oncogene 9: 1799-1805
59. Moll UM, Laquaglia M, Benard J and Riou G (1995) Wild-type p53 protein undergoes cytoplasmic sequestration in undifterentiated neuroblastomas but not in differentiated tumors. Proc Natl Acad Sci USA 10: 4407-4411
60. Nitschke R, Smith E and Shochat S (1988) Localized neuroblastoma treated by surgery: a Pediatric Oncology Group study. J Clin Oncol 6: 1271-1278
61. Nylander K, Stenling R, Gustafsson H. Zackrisson B and Roos G (1995) p53 expression and cell proliferation in squamous cell carcinomas of the head and neck. Cancer 75: 87-93
62. Oltval ZN, Milliman CL and Korsmeyer SJ (1993) Bcl-2 heterodimerized in vivo with a conserved homolog, bax, that accelerates programed cell death. Cell 74: 609-619
63. Pezzella F, Tse AG, Cordell JL, Pulford KA, Gatter KC and Mason DY (1990) Expression of the bcl-2 oncogene protein is not specific for the 14;18 chromosomal translocation. Am J Pathol 137: 225-232
64. Ramani P and Lu QL (1994) Expression of bcl-2 gene product in neuroblastoma. J Pathol 172: 273-278
65. Rao L, Debbas M, Sabbatini P, Hockenbery D, Korsmeyer S and White E (1992) The adenovirus E1A proteins induce apoptosis, which is inhibited by the E1B 19-kDa and Bcl-2 proteins. Proc Natl Acad Sci USA 89: 7742-7746
66. Reed JC (1994) Bcl-2 and the regulation of programmed cell death. J Cell Biol 124: 1-6
67. Rohrer H, Acheson AL, Thibault J and Thoenen H (1986) Developmental potential of quail dorsal root ganglion cells analyzed in vitro and in vivo. J Neurosci 6: 2616-2624
68. Selvakumaran M, Lin H-K, Miyashita T, Wang HG, Krajewski S, Reed JC, Hoffman B and Liehermann D (1994) Immediate early up-regulation of bax expression by p53 but not TGFβ1: a paradigm for distinct apoptotic pathways. Oncogene 9: 1791-1798
69. Shaw P, Bovey R, Tardy S, Sahli R, Sordat B and Costa J (1992) Induction of apoptosis by wild-type p53 in a human colon tumor-derived cell line. Proc Natl Acad Sci USA 89: 4495-4499
70. Shimada H, Chatten J, Newton WA, Sachs N, Hamoudi A, Chiba T, Marsden H and Misugi K (1984) Histopathologic prognostic factors in neuroblastoma tumors: definition of subtypes of ganglioneuroblastoma and an age linked classification of neuroblastoma. J Natl Cancer Inst 73: 405-416
71. Tannok IF (1968) The relationship between cell proliferation and the vascular system in a transplanted mouse mammary tumor. Br J Cancer 22: 258-273
72. Tannock IF (1970) Population kinetics of carcinoma cells, capillary endothelial cells, and fibroblasts in a transplanted mouse mammary tumor. Cancer Res 30: 2470-2476
73. Thompson WD, Shiach KJ, Fraser RA, McIntosh LC and Simpson JG (1987) Tumours acquire their vasculature by vessel incorporation, not vessel ingrowth. J Pathol 151: 323-332
74. Veis DJ, Sorenson CM, Shutter JR and Korsmeyer SJ (1993) bcl-2 deficient mice demonstrate fulminant lymphoid apoptosis, polycystic kidneys, and hypopigmented hair. Cell 75: 229-240
75. Vogan K, Bernstein M, Leclerc JM, Brisson L, Brossard J, Brodeur GM, Pelletier J and Gros P (1993) Absence of p53 gene mutations in primary neuroblastomas. Cancer Res 53: 5269-5273
76. Voijtesek B and Lane DP (1993) Regulation of p53 protein expression in human breast cancer cell lines. J Cell Sci 105: 607-612
77. White AE, Livanos EM and Tisty TD (1994) Differential disruption of genomic integrity and cell cycle regulation in normal human fibroblasts by HPV oncoproteins, Genes Dev 8: 666-677
78. While E (1994) p53. guardian of Rb. Nature 371: 21-22
79. Wyllie AH, Kerr JFR and Currie AR (1980) Cell death: the significance of apoptosis. Int Rev Cytol 68: 251-306
80. Yonish-Rouach E, Resnitsky D, Lotem J, Sacbs L, Kimchi A and Oren M (1991) Wild-type p53 induces apoptosis of myeloid leukaemic cells that is inhibited by interleukin 6, Nature 352: 345-347
81. Zambetti G, Bargonetti J, Walker K, Prives C and Levine AJ (1992) Wild-type p53 mediates positive regulation of gene expression through a specific DNA sequence element. Genes Dev 6: 1143-1152